Impax EVP finance, CFO resigns

HAYWARD, Calif. — One of Impax Labs' top executives is leaving the company, the drug maker announced Friday.

Impax said EVP finance and CFO Arthur Koch would resign to pursue other opportunities. VP finance Bryan Reasons has been appointed acting CFO as the company searches for a successor to Koch.

"During the past seven years that Arthur Koch has been with us, the company has grown tremendously, and I deeply appreciate his service to the company," president and CEO Larry Hsu said. "Bryan Reasons is an able and experienced financial executive who will be the interim CFO, reporting to me, as we conduct an external search for a permanent CFO."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.